Patient Square Capital as of March 31, 2025
Portfolio Holdings for Patient Square Capital
Patient Square Capital holds 19 positions in its portfolio as reported in the March 2025 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Roivant Sciences SHS (ROIV) | 52.1 | $126M | 13M | 10.09 | |
| Insmed Com Par $.01 (INSM) | 10.4 | $25M | 330k | 76.29 | |
| Liquidia Corporation Com New (LQDA) | 9.3 | $23M | 1.5M | 14.75 | |
| Eyepoint Pharmaceuticals Com New (EYPT) | 3.3 | $8.0M | 1.5M | 5.42 | |
| Ocular Therapeutix (OCUL) | 2.8 | $6.7M | 920k | 7.33 | |
| Cullinan Oncology (CGEM) | 2.8 | $6.7M | 879k | 7.57 | |
| Nurix Therapeutics (NRIX) | 2.2 | $5.3M | 447k | 11.88 | |
| Mirum Pharmaceuticals (MIRM) | 2.2 | $5.2M | 116k | 45.05 | |
| Enliven Therapeutics (ELVN) | 2.1 | $5.0M | 254k | 19.68 | |
| Scholar Rock Hldg Corp (SRRK) | 2.0 | $5.0M | 154k | 32.15 | |
| Disc Medicine (IRON) | 1.7 | $4.1M | 83k | 49.64 | |
| Agios Pharmaceuticals (AGIO) | 1.7 | $4.1M | 140k | 29.30 | |
| Kymera Therapeutics (KYMR) | 1.6 | $3.9M | 142k | 27.37 | |
| Pharvaris N V (PHVS) | 1.6 | $3.9M | 246k | 15.70 | |
| Allogene Therapeutics (ALLO) | 1.4 | $3.5M | 2.4M | 1.46 | |
| Blueprint Medicines (BPMC) | 1.4 | $3.4M | 39k | 88.51 | |
| Intellia Therapeutics (NTLA) | 0.7 | $1.7M | 233k | 7.11 | |
| Soleno Therapeutics (SLNO) | 0.5 | $1.3M | 19k | 71.45 | |
| Vyne Therapeutics (VYNE) | 0.2 | $406k | 257k | 1.58 |
